window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : November 16, 2025

  • News
  • About Us
Contact Us

CDMO

  • Biologics & Biosimilars,Biomanufacturing,CDMOs & Manufacturing,European biotech,Pharmaceuticals and therapeutics

    Cytovance Biologics celebrates 20 years advancing biopharma manufacturing in Oklahoma City

    Cytovance Biologics, a contract development and manufacturing organisation serving the [...]

    November 14, 2025
  • Biomanufacturing,CDMOs & Manufacturing,Partnerships & Funding,Technology and platforms

    Lonza to acquire Redberry to expand rapid microbiology testing for pharmaceutical quality control

    Lonza has signed an agreement to acquire Redberry, a French [...]

    November 6, 2025
  • Artificial Intelligence,Biologics & Biosimilars,CDMOs & Manufacturing,Clinical studies,Market Access & Commercialization

    KBI Biopharma CBO Katie Edgar on ADCs, biologics, and digital innovation in drug development

    Discover Pharma caught up with Katie Edgar, chief business officer [...]

    November 13, 2025
  • Artificial Intelligence,Biotech,CDMOs & Manufacturing

    Pharma leaders on AI, automation, and ESG: How CDMOs are reshaping development at CPHI Frankfurt 2025

    At another of this year’s CPHI Frankfurt 2025 roundtable, executives [...]

    November 6, 2025
  • Biologics & Biosimilars,Biomanufacturing,Biotech,CDMOs & Manufacturing,Clinical Development,Events and Conferences,Partnerships & Funding,Pharmaceuticals and therapeutics

    Personal connections at CPhI Frankfurt 2025: How trust drives long-term pharma relationships

    A roundtable at CPhI Frankfurt 2025 with industry leaders from [...]

    November 5, 2025
  • Biologics & Biosimilars,Biomanufacturing,CDMOs & Manufacturing,Movers & Shakers,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    CDMO Argonaut appoints Rick Hancock to drive next phase of biologics and commercial manufacturing

    Argonaut Manufacturing Services has named Rick Hancock as chief executive [...]

    November 5, 2025
  • Biomanufacturing,Biotech,CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics

    BBG Advanced Therapies and CELLforCURE partner to provide transatlantic ATMP manufacturing solutions

    BBG Advanced Therapies (BBGAT), a subsidiary of BioBridge Global and [...]

    October 7, 2025
  • Biomanufacturing,CDMOs & Manufacturing,Cell & Gene Therapy,Clinical Development,Drug Development,Pharmaceuticals and therapeutics,Technology and platforms

    ReiThera: Commercial CDMO capabilities key to manage ‘volatile’ biotech market

    ReiThera will begin commercial production in 2026, a milestone the [...]

    September 25, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics,Technology and platforms

    RION partners with Lonza to scale manufacturing of exosome-based therapeutics

    RION, a commercial and clinical-stage regenerative medicine company pioneering platelet-derived [...]

    September 23, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    eXmoor Pharma and Siam Bioscience partner to expand cell and gene therapy services in Southeast Asia

    eXmoor Pharma and Siam Bioscience have announced a strategic partnership [...]

    September 23, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Clairity raises $43 million to launch FDA-authorized AI platform for breast cancer risk prediction
    Categories: Artificial Intelligence, Biotech, Clinical Development, Diagnostics, Digital Health, Drug Development, Global health, Healthcare leadership, Precision medicine, Women's Health
  • FDA approves Kura and Kyowa Kirin’s ziftomenib for relapsed or refractory AML
    Categories: Drug approval, Oncology, Pharmaceuticals and therapeutics
  • Successful treatment for ALS could deliver billions in global value
    Categories: Neurosciences, Rare Diseases, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top